3-8745503-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_033337.3(CAV3):​c.115-23G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0803 in 1,594,502 control chromosomes in the GnomAD database, including 5,703 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.091 ( 750 hom., cov: 32)
Exomes 𝑓: 0.079 ( 4953 hom. )

Consequence

CAV3
NM_033337.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: 1.08

Publications

3 publications found
Variant links:
Genes affected
CAV3 (HGNC:1529): (caveolin 3) This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites. [provided by RefSeq, Jul 2008]
OXTR (HGNC:8529): (oxytocin receptor) The protein encoded by this gene belongs to the G-protein coupled receptor family and acts as a receptor for oxytocin. Its activity is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. The oxytocin-oxytocin receptor system plays an important role in the uterus during parturition. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 3-8745503-G-C is Benign according to our data. Variant chr3-8745503-G-C is described in CliVar as Benign. Clinvar id is 31737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-8745503-G-C is described in CliVar as Benign. Clinvar id is 31737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-8745503-G-C is described in CliVar as Benign. Clinvar id is 31737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-8745503-G-C is described in CliVar as Benign. Clinvar id is 31737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAV3NM_033337.3 linkc.115-23G>C intron_variant Intron 1 of 1 ENST00000343849.3 NP_203123.1 P56539
CAV3NM_001234.5 linkc.115-23G>C intron_variant Intron 1 of 2 NP_001225.1 P56539
OXTRXR_007095681.1 linkn.1885-2901C>G intron_variant Intron 4 of 4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAV3ENST00000343849.3 linkc.115-23G>C intron_variant Intron 1 of 1 1 NM_033337.3 ENSP00000341940.2 P56539
CAV3ENST00000397368.2 linkc.115-23G>C intron_variant Intron 1 of 2 1 ENSP00000380525.2 P56539
CAV3ENST00000472766.1 linkn.155+11513G>C intron_variant Intron 1 of 2 2

Frequencies

GnomAD3 genomes
AF:
0.0913
AC:
13886
AN:
152018
Hom.:
745
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.126
Gnomad AMI
AF:
0.126
Gnomad AMR
AF:
0.0530
Gnomad ASJ
AF:
0.0740
Gnomad EAS
AF:
0.00810
Gnomad SAS
AF:
0.0324
Gnomad FIN
AF:
0.125
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0858
Gnomad OTH
AF:
0.0627
GnomAD2 exomes
AF:
0.0695
AC:
17134
AN:
246556
AF XY:
0.0683
show subpopulations
Gnomad AFR exome
AF:
0.125
Gnomad AMR exome
AF:
0.0287
Gnomad ASJ exome
AF:
0.0751
Gnomad EAS exome
AF:
0.00441
Gnomad FIN exome
AF:
0.129
Gnomad NFE exome
AF:
0.0827
Gnomad OTH exome
AF:
0.0607
GnomAD4 exome
AF:
0.0791
AC:
114090
AN:
1442366
Hom.:
4953
Cov.:
29
AF XY:
0.0775
AC XY:
55731
AN XY:
718650
show subpopulations
African (AFR)
AF:
0.121
AC:
4001
AN:
33028
American (AMR)
AF:
0.0308
AC:
1374
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.0772
AC:
2010
AN:
26034
East Asian (EAS)
AF:
0.00197
AC:
78
AN:
39630
South Asian (SAS)
AF:
0.0374
AC:
3205
AN:
85726
European-Finnish (FIN)
AF:
0.126
AC:
6707
AN:
53292
Middle Eastern (MID)
AF:
0.0278
AC:
159
AN:
5728
European-Non Finnish (NFE)
AF:
0.0839
AC:
91835
AN:
1094424
Other (OTH)
AF:
0.0789
AC:
4721
AN:
59822
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
4647
9293
13940
18586
23233
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3360
6720
10080
13440
16800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0914
AC:
13910
AN:
152136
Hom.:
750
Cov.:
32
AF XY:
0.0920
AC XY:
6843
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.126
AC:
5240
AN:
41530
American (AMR)
AF:
0.0528
AC:
807
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0740
AC:
257
AN:
3472
East Asian (EAS)
AF:
0.00811
AC:
42
AN:
5176
South Asian (SAS)
AF:
0.0326
AC:
157
AN:
4816
European-Finnish (FIN)
AF:
0.125
AC:
1322
AN:
10580
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0858
AC:
5831
AN:
67968
Other (OTH)
AF:
0.0630
AC:
133
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
627
1254
1882
2509
3136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0898
Hom.:
119
Bravo
AF:
0.0866
Asia WGS
AF:
0.0420
AC:
144
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 15, 2012
Leiden Muscular Dystrophy (CAV3)
Significance:not provided
Review Status:no classification provided
Collection Method:curation

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.4
DANN
Benign
0.78
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57159780; hg19: chr3-8787189; API